Does PONATINIB Cause Neoplasm progression? 320 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 320 reports of Neoplasm progression have been filed in association with PONATINIB (Iclusig). This represents 3.2% of all adverse event reports for PONATINIB.
320
Reports of Neoplasm progression with PONATINIB
3.2%
of all PONATINIB reports
144
Deaths
121
Hospitalizations
How Dangerous Is Neoplasm progression From PONATINIB?
Of the 320 reports, 144 (45.0%) resulted in death, 121 (37.8%) required hospitalization, and 9 (2.8%) were considered life-threatening.
Is Neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PONATINIB. However, 320 reports have been filed with the FAERS database.
What Other Side Effects Does PONATINIB Cause?
Death (1,735)
Off label use (1,071)
Product dose omission issue (817)
Fatigue (687)
Rash (639)
Headache (553)
Pyrexia (542)
Nausea (466)
Hospitalisation (459)
Constipation (435)
What Other Drugs Cause Neoplasm progression?
PALBOCICLIB (10,885)
SUNITINIB MALATE (1,920)
CYCLOPHOSPHAMIDE (1,588)
CARBOPLATIN (1,370)
AXITINIB (1,315)
DOXORUBICIN (1,276)
LETROZOLE (1,225)
PACLITAXEL (1,180)
CRIZOTINIB (1,161)
VINCRISTINE (1,106)
Which PONATINIB Alternatives Have Lower Neoplasm progression Risk?
PONATINIB vs PONATINIB\PONATINIB
PONATINIB vs PONESIMOD
PONATINIB vs PORACTANT ALFA
PONATINIB vs PORFIMER
PONATINIB vs POSACONAZOLE